These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14172902)

  • 21. Familial aquagenic urticaria.
    Bonnetblanc JM; Andrieu-Pfahl F; Meraud JP; Roux J
    Dermatologica; 1979; 158(6):468-70. PubMed ID: 38152
    [No Abstract]   [Full Text] [Related]  

  • 22. A controlled trial of therapy in chronic urticaria.
    Harvey RP; Wegs J; Schocket AL
    J Allergy Clin Immunol; 1981 Oct; 68(4):262-6. PubMed ID: 6116728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound 48/80: a potent histamine liberator.
    PATON WD
    Br J Pharmacol Chemother; 1951 Sep; 6(3):499-508. PubMed ID: 14878986
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiation-released histamine in the rhesus monkey as modified by mast-cell depletion and antihistamine.
    Doyle TF; Strike TA
    Experientia; 1977 Aug; 33(8):1047-9. PubMed ID: 70375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liberation and depletion of histamine from human skin; effect of an antihistamine and hydrocortisone on the activity of the histamine liberator, compound 48/80.
    BERNSTEIN IL; FEINBERG SM
    J Allergy; 1956 May; 27(3):231-5. PubMed ID: 13318859
    [No Abstract]   [Full Text] [Related]  

  • 26. [USE OF DIAZOLINE IN PRURITIC DERMATOSES].
    SKRIPKIN IK
    Vestn Dermatol Venerol; 1963 Sep; 37():85-6. PubMed ID: 14097175
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria.
    Brunet C; Bédard PM; Hébert J
    J Allergy Clin Immunol; 1990 Nov; 86(5):787-93. PubMed ID: 1699989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Findings in intracutaneous injection of eledoisin-like substance and physalaemin. Supplement: reaction and neuromorphological changes of the dermal peripheral nerves].
    Fujinami T; Okumura Y; Kawazu T; Matauda H
    Arerugi; 1970 Aug; 19(8):637-40. PubMed ID: 4394058
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular reactions to histamine and compound 48/80 in human skin: suppression by a histamine H2-receptor blocking agent.
    Marks R; Greaves MW
    Br J Clin Pharmacol; 1977 Jun; 4(3):367-9. PubMed ID: 901705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salt-dependent aquagenic urticaria in children: Report of two cases.
    Napolitano M; Gallo R; Donnarumma M; Patruno C
    Pediatr Allergy Immunol; 2018 May; 29(3):324-326. PubMed ID: 29337390
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticaria.
    Bédard PM; Brunet C; Pelletier G; Hébert J
    J Allergy Clin Immunol; 1986 Dec; 78(6):1121-5. PubMed ID: 2431027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACTION SPECTRUM AND OTHER STUDIES ON PATIENTS WITH PORPHYRIA.
    MAGNUS IA
    S Afr J Lab Clin Med; 1963 Dec; 14():238-41. PubMed ID: 14110517
    [No Abstract]   [Full Text] [Related]  

  • 33. [INFLUENCE OF GLYCOACTIVE STEROIDS ON SPECIFIC AND ASPECIFIC CUTANEOUS REACTIVITY].
    CINELLI P; RICCA M; ONESTI S; PASSALEVA A; RICCI M
    Riforma Med; 1964 Aug; 78():965-7. PubMed ID: 14207448
    [No Abstract]   [Full Text] [Related]  

  • 34. CHEMICAL MEDIATORS OF THE ACUTE INFLAMMATORY REACTION.
    ROCHAESILVA M
    Ann N Y Acad Sci; 1964 Aug; 116():899-911. PubMed ID: 14212863
    [No Abstract]   [Full Text] [Related]  

  • 35. Histamine induced high mobility group box-1 release from vascular endothelial cells through H
    Gao S; Liu K; Ku W; Wang D; Wake H; Qiao H; Teshigawara K; Nishibori M
    Front Immunol; 2022; 13():930683. PubMed ID: 36275732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Review of Aquagenic Urticaria-Subgroups and Treatment Options.
    Rujitharanawong C; Kulthanan K; Tuchinda P; Chularojanamontri L; Metz M; Maurer M
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2154-2162. PubMed ID: 35533998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Corticosteroids and antihistaminics combined in the treatment of dermatoses].
    Peirone F
    Minerva Med; 1967 Jan; 58(9):285-8. PubMed ID: 4381515
    [No Abstract]   [Full Text] [Related]  

  • 38. [Aquagenic urticaria. A case report].
    Kreft B; Wohlrab J; Marsch WC
    Hautarzt; 2014 Feb; 65(2):130-2. PubMed ID: 24141429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice.
    Sugimoto Y; Umakoshi K; Nojiri N; Kamei C
    Eur J Pharmacol; 1998 Jun; 351(1):1-5. PubMed ID: 9698198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission.
    Jacques P; Lavoie A; Bédard PM; Brunet C; Hébert J
    J Allergy Clin Immunol; 1992 Jun; 89(6):1139-43. PubMed ID: 1376735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.